Study for the relationship between blood C-reactive protein (CRP) levels and blood tofacitinib levels in ulcerative colitis
Not Applicable
Recruiting
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000050907
- Lead Sponsor
- Wakayama medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant or lactating women. 2.Patients with a history of hypersensitivity to Xeljanz. 3.Patients who have previously undergone surgical treatment for ulcerative colitis. 4.Patients who are dependent on parenteral nutrition. 5.Patients with Child-pugh Class C hepatic impairment. 6.Patients with active tuberculosis or untreated latent tuberculosis. 7.Patients with a history of malignancy within the last 5 years. 8.Patients with a history of opportunistic infections or immunodeficiency syndromes. 9.Patients with mental illness. 10.Patients who are judged by the physician to be unsuitable for the safe conduct of the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method